AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Study: Self exam increases women's concerns, has no effect on mortality.

Women's Health Weekly

| April 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 1 - (NewsRx.com & NewsRx.net) -- Breast self-examination (BSE) should not be seen as a cheaper alternative to mammography, and people who still advocate it as an effective way of reducing breast cancer mortality are doing women a disservice, according to a presentation on March 16, 2004, at the 4th European Breast Cancer Conference.

Vladimir Semiglazov conducted and analyzed a randomized, controlled trial of BSE in nearly 100,000 Russian women between 1985 and 2003. The women had been taught how to examine their breasts correctly, but even so there was no reduction in deaths from breast cancer in the BSE group.

And not only did self-examination not affect mortality, it also meant that more women in the BSE group consulted doctors for benign breast lesions than those in the control group.

Lars Holmberg, a professor at the Regional Oncologic Center, Uppsala, Sweden, commented on the study and explained why BSE should not be promoted as something that can decrease mortality from breast cancer.

"Breast self-examination has been widely advocated in the belief that it is beneficial," said Holmberg. "In fact we now know that it can be positively harmful. ...

Related articles from newspapers, magazines, journals, and more
Two drinks a day increases risk of breast cancer, study shows.
Magazine article from: Women's Health Weekly March 4, 2004 700+ words
...MD, founder of The Breast Cancer Care & Research...or hopeful time for breast cancer research and treatment...for their particular breast cancer." This article was prepared by Women's Health Weekly editors from staff...
Irsogladine side-steps angiogenic function to stop breast cancer metastasis.
Magazine article from: Women's Health Weekly March 25, 2004 700+ words
...agent, irsogladine. Breast Cancer Res Treat, 2004...publisher of the journal Breast Cancer Research and Treatment...Gastroenterology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Change on enzyme gene may associate with invasive disease.(breast cancer...
Magazine article from: Women's Health Weekly January 9, 2003 700+ words
...than women without breast cancer carried a polymorphism...MMP-3 * Women whose breast cancer had spread were more...metastasis in women with breast cancer This article was prepared by Women's Health Weekly editors from staff...
Protein tyrosine phosphatase gamma is a tumor suppressor gene in breast cancer.
Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...independent growth of breast cancer cells in soft agar...PTP gamma) in human breast cancer cell line MCF-7...Enzymology, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
Magazine article from: Women's Health Weekly May 6, 2004 700+ words
...Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR...Biotechnology, Oncogenesis and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff and other...
Older breast cancer patients in Canada benefit from early detection.
Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...year survival of 2192 breast cancer women diagnosed between...Survival of women with breast cancer in Ottawa, Canada...amp; Mortality, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Gene patterns in the ERBB2/TOP2A region of breast cancer influence outcomes.
Magazine article from: Women's Health Weekly June 17, 2004 700+ words
...ERBB2/TOP2A region of breast cancer influence outcomes...ERBB2/TOP2A region in breast cancer. Gene Chromosome Cancer...Oncogenesis, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Cystatin M is a novel candidate tumor suppressor gene for breast cancer.
Magazine article from: Women's Health Weekly December 30, 2004 700+ words
...suppressor gene for breast cancer," Zhang concluded...suppressor gene for breast cancer. Cancer Res, 2004...Suppressor Gene and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA